In patients with lung cancer, sequencing bronchoalveolar lavage (BAL) cell-free DNA is more sensitive for identifying genomic alterations than sequencing plasma cell-free BAL and may provide an ...
The increased understanding of the EGFR pathway in NSCLC with the identification of activating mutations in the tyrosine kinase domain of EGFR and the impressive clinical results observed with ...
In patients with lung cancer, sequencing bronchoalveolar lavage (BAL) cell-free DNA is more sensitive for identifying genomic alterations than sequencing plasma cell-free BAL and may provide an ...
To date, eight randomized clinical trials have demonstrated that first-line treatment with TKIs in advanced NSCLC patients harboring activating EGFR mutations is associated with significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback